State Street Corp Bio Xcel Therapeutics, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 464,908 shares of BTAI stock, worth $548,591. This represents 0.0% of its overall portfolio holdings.
Number of Shares
464,908
Previous 440,332
5.58%
Holding current value
$548,591
Previous $1.3 Million
1.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BTAI
# of Institutions
77Shares Held
6.6MCall Options Held
85KPut Options Held
221K-
Black Rock Inc. New York, NY1.33MShares$1.57 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$1.3 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN579KShares$683,4130.0% of portfolio
-
Geode Capital Management, LLC Boston, MA458KShares$540,3450.0% of portfolio
-
Armistice Capital, LLC New York, NY371KShares$437,7480.01% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $33.1M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...